New NIH stimulus grants go live

The National Institutes of Health is inviting researchers to apply for newly created grants, funded by the $10 billion that the agency netted in the recently-signed economic stimulus legislation. The new initiative, called the NIH Challenge Grants in Health and Science Research, will make a pot of $200 million of that stimulus cash available for projects focusing on a broad array of more than one hundred topics, from behavioral sciences and genomics to stem cells and translational science. Thes

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The National Institutes of Health is inviting researchers to apply for newly created grants, funded by the $10 billion that the agency netted in the recently-signed economic stimulus legislation. The new initiative, called the NIH Challenge Grants in Health and Science Research, will make a pot of $200 million of that stimulus cash available for projects focusing on a broad array of more than one hundred topics, from behavioral sciences and genomics to stem cells and translational science. These areas, according to the NIH, reflect a "focus on specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods that would benefit from an influx of funds to quickly advance the area in significant ways." The agency said on its website that it expects to fund 200 or more projects over the next two years. Submissions are due by April 27, 2009, so get cracking on that proposal! Find all the information you'll need to apply for a Challenge Grant by clicking linkurl:here.;http://grants.nih.gov/grants/funding/challenge_award/
**__Related stories:__***linkurl:NIH stimulus to fund old grants;http://www.the-scientist.com/blog/display/55438/
[19th February 2009]*linkurl:NIH wins stimulus jackpot;http://www.the-scientist.com/blog/display/55418/
[12th February 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies